Details for New Drug Application (NDA): 061009
✉ Email this page to a colleague
NDA 061009 describes TERRAMYCIN-POLYMYXIN, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the TERRAMYCIN-POLYMYXIN profile page.
The generic ingredient in TERRAMYCIN-POLYMYXIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.
The generic ingredient in TERRAMYCIN-POLYMYXIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.
Summary for 061009
| Tradename: | TERRAMYCIN-POLYMYXIN |
| Applicant: | Pfizer |
| Ingredient: | oxytetracycline hydrochloride; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;VAGINAL | Strength | EQ 100MG BASE;100,000 UNITS | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
